AUG 18, 2026 · JOURNAL ARTICLE
Serum Asprosin Levels in Patients with Hidradenitis Suppurativa: A Case–Control Study
Diagnostics
Single-center case–control study with modest sample size and a biomarker endpoint that lost statistical significance after adjustment for confounders, offering early exploratory evidence but not sufficient to establish clinical utility.
Reported
Serum asprosin (HS patients)30.07 ± 28.15 ng/mL
Serum asprosin (healthy controls)40.94 ± 33.11 ng/mL
p-value (unadjusted comparison)0.028